期刊文献+

线粒体功能障碍在肺动脉高压形成中的作用机制 被引量:1

Mechanismas of Mitochondrial Dysfunction in the Formation of Pulmonary Hypertension
下载PDF
导出
摘要 肺动脉高压在病理上表现为一种增殖性疾病。研究显示,线粒体功能障碍参与肺血管及右心室的重塑。线粒体功能障碍涉及三羧酸循环、电子呼吸链、线粒体膜电位、线粒体钙储存、线粒体动力学、线粒体自噬以及线粒体生物发生等。线粒体以上各方面的异常均参与了肺动脉高压的形成。因此,恢复线粒体功能可能成为治疗肺动脉高压的新策略。本文主要综述了线粒体功能障碍在肺动脉高压形成中的作用机制。 Pulmonary hypertension is a proliferative disease pathologically.Studies have shown that mitochondrial dysfunction is involved in remodeling of pulmonary vessels and right ventricle.Mitochondrial dysfunction involves the tricarboxylic acid cycle,electronic respiratory chain,mitochondrial membrane potential,mitochondrial calcium storage,mitochondrial dynamics,mitochondrial autophagy,mitochondrial biogenesis and so on.The abnormalities of the above aspects of mitochondria are involved in the formation of pulmonary hypertension.Therefore,restoring mitochondrial function may be a new strategy to treat pulmonary hypertension.This paper reviewed the mechanisms of mitochondrial dysfunction in the formation of pulmonary hypertension.
作者 崔志峰 孙佳伟 刘美洋 宫小薇 袁雅冬 CUI Zhifeng;SUN Jiawei;LIU Meiyang;GONG Xiaowei;YUAN Yadong(Department of Respiratory and Critical Care Medicine,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)
出处 《实用心脑肺血管病杂志》 2022年第7期24-28,共5页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金 河北省重点研发计划项目(21377701D)。
关键词 肺动脉高压 线粒体 线粒体功能障碍 Pulmonary arterial hypertension Mitochondrion Mitochondrial dysfunction
  • 相关文献

参考文献2

二级参考文献14

  • 1Tao WANG,Zhen-xiang ZHANG,Yong-jian XU,Qing-hua HU.5-Hydroxydecanoate inhibits proliferation of hypoxic human pulmonary artery smooth muscle cells by blocking mitochondrial K_(ATP) channels[J].Acta Pharmacologica Sinica,2007,28(10):1531-1540. 被引量:11
  • 2Park J. STAT3 inhibits the degradation of HIF-1α by pVHL- mediated ubiquitlnation. Exp Mol Med, 2008, 40: 479-485.
  • 3Lakham NJ, Sarkar MA, Venitz J, et al. 2-methoxyeslracliol, a promising antieaneer drug. Pharmaeolherapy, 2003, 23: 165-172.
  • 4Miyamoto N, Mandai M, Takagi H, et al. Contrasting effect of estrogen on VEGF induction under different oxygen status and it s role in murine ROE Ophthalmol Vis Sci, 2002, 43: 2007-2014.
  • 5Lippert C, Seeger H, Mueck AO, et al. The effects of A-ring and D-ring metaboliles of estradiol on the proliferation of vascular endothelial cells. Life Sci, 2000, 67: 1653-1658.
  • 6Dupont J, Karas M, LeRoith D. The potentiation of estrogen of insulin like growth factor Ⅰ action in MCF-7 haman cancer cells includes cell cycle components. J Bio Chem, 2000, 275: 35893-35900.
  • 7Suzuma I, Mandai M, Takagi H, et al. 17-Eslradiol increases VEGF receptor-2 and promotes DNA synthesis in relinnl microvascular endothelial cells. Invest Opthahnol Vis Sci, 1999, 40: 2122-2129.
  • 8Geraldes P, Sirois MG, Bernatchcz PN, et el. Estrogen regulation of endothelial and smooth muscle cell migration and proliferationw. Role of p38 and p42/44 milogen-aetivate protein kinase. Arterioseler Thromb Vase Biol, 2002, 22: 1585-1590.
  • 9Alsharnoubi JM, Odhmd HH, Saugstad OD. Nicotine does not influence NF-κB activity in neonalal mice reoxygenated with room-air or 100% oxygen. J Matern Fetal Neonatal Med, 2012, 25: 2102-2105.
  • 10Gestl SA, Green MD, Shearer DA, et al. Expression of UGT2B7, a UDP-Glucuronasyltransferase hnplieated in the Metabolism of 4-Hydroxyestrone and All-Trans lRetinoie Acid, in Normal Human Breast Parenehyma and in lnvasive and in Situ Breast Cancers.Am J Pathol, 2002, 4: 1467-1479.

共引文献11

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部